About
NovaResp Technologies Inc. is a Canadian medical technology company located in Halifax, Nova Scotia. Founded in 2016, the company specializes in respiratory artificial intelligence solutions for the treatment of obstructive sleep apnea (OSA). Its flagship product, cMAP® (continuous Management of Airway Pressure), is an AI-driven software platform designed to enhance existing CPAP machines. cMAP® utilizes predictive algorithms to anticipate apnea episodes in real time, allowing for more comfortable air pressure delivery during therapy. The technology aims to address common challenges associated with traditional CPAP devices, such as discomfort and improper pressure settings, which often lead to patient discontinuation. NovaResp is focused on developing a new generation of portable, wearable, and energy-efficient CPAP machines, including battery-enabled options. The company serves patients diagnosed with OSA, healthcare providers, and sleep clinics, and is currently conducting pre-market clinical trials to validate the effectiveness of its cMAP®-enabled devices. NovaResp was recognized as the 2025 “Innovative Business of the Year” by the Halifax Chamber of Commerce for its contributions to respiratory AI and sleep apnea treatment.
Technologies
Keywords
Company Information
-
Employees 19
-
Founded 2016
-
Total Funding $2000000
Location
1344 Summer St, Halifax, Nova Scotia, Canada, B3H 0A8
